August 2019 FDA Recall Vivitrol by Alkermes Inc
D-1846-2019 - Labeling

This Class II drug recall was voluntarily initiated by Alkermes Inc on August 8, 2019 for the product Vivitrol. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1846-2019

Reason for Recall
Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.
Initiated
08-08-2019
Reported
09-04-2019
Quantity
6,514 kits

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Distributed Nationwide in the USA
Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial. Each Carton Contains: 1) One vial of 380 mg of Vivitrol, 2) One vial containing 4 mL of diluent, 3) One 5-mL prepackaged syringe, 4) One 20-gauge 1-inch needle, 5) Two 20-gauge 1.5-inch safety needles, 6) Two 20-gauge 2-inch safety needles. Rx Only. Manufactured and marketed by: Alkermes, Inc. Kit NDC: 65757-300-01

Batch or Lot Expiration Information

Lot# Lot 2018-3010T Exp 8/2021

Affected Packages Involved in this Recall